Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
American Healthcare REIT (AHR) · oqro.io/stocks/AHR · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Questions about American Healthcare REIT insider trading
Have American Healthcare REIT insiders bought shares recently?
No open-market purchase by an insider of American Healthcare REIT was filed in the last 90 days. The latest on record was on May 22, 2024.
How often do American Healthcare REIT insiders buy and sell shares?
Since 2017, American Healthcare REIT insiders reported 192 open-market purchases and 15 sales on Forms 4 and 5, with purchases in 4 different years, most recently 2024.
Who is selling American Healthcare REIT stock?
In the last 90 days, 2 insiders of American Healthcare REIT (AHR) reported 4 open-market sales worth $453K in total on SEC Form 4. The largest seller by value was Mark E. Foster, with $305K. Many insider sales follow a plan set in advance or cover taxes on stock awards; the filing says what was sold, not the reason.
Do members of Congress trade AHR?
No trade in American Healthcare REIT (AHR) was disclosed by a member of Congress in the last 12 months.
When does American Healthcare REIT report its next results?
American Healthcare REIT's next results are expected on Feb 22, 2027. The date can move until the company confirms it. Insiders often trade in the weeks right after results.
Where does this data come from?
From official filings only: SEC Forms 4, 5 and 144 for insiders, House and Senate periodic transaction reports for Congress, SEC Form 13F for funds, Form 8-K for company events and USAspending for federal contracts. Every record on OQRO links to its source. It is public data, not investment advice.
AHR price and disclosed activity
+16.9% (+$8.31) from Nov 20, 2025 to Nov 20, 2026 · adjusted daily closes
Adjusted close went from $49.23 on Nov 20, 2025 to $57.54 on Nov 20, 2026 (+16.9%). Disclosed in this range: 6 insider trades, 4 pre-arranged insider sales, 0 Congress trades, and 19 13F position changes for 4 quarters ending in it.
$40$45$50$55$60$65$57.54
DecJan 2026FebMarAprMayJunJulAugSepOctNov
13F holdings, by quarter end
Insider and Congress marks sit on the trade date stated in the filing; solid is a purchase, hollow a sale. A number means several trades too close to tell apart at this range: pick a shorter range or open it for the list. Fund 13F reports are quarter-end snapshots filed up to 45 days later, so they are shown under the chart across the quarter they describe, not on the price line. Congress amounts are official ranges; mark size uses the lower bound. Past moves are not a forecast.Show the 10 trades in this range as a list
Counts of filings OQRO holds, by the date each was filed or the award started. Every figure links to its official SEC, House, Senate or USAspending record.
Health Care REITs company based in Irvine, California.
Last 12 months
+16.9%
S&P 500 +5.7% over the same dates
Market value
$13.4B
Close of Nov 20, 2026 × shares outstanding (per ADS where it applies)
S&P 500 +5.7% over the same dates. Prices adjusted for splits and dividends.
Short interest: 33.7M shares sold short (14.5% of shares outstanding), +1.5% vs the previous count, 10.3 days of normal trading to buy them back. FINRA, as of Oct 30, 2026. Short interest history
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Since Nov 19, 2025, AHR is up 16.3% and the index fund is up 4.1%: 12 points ahead of the market. Traders call a stock that beats the index over a period a relative-strength leader.
How much AHR moves
A usual day
±1.0%Half of the sessions moved less than this, half moved more.
Daily range (ATR 14)
2.3%How far the price usually travels in a session, the gap from the day before included. Wilder's 14-session average.
Largest one-day fall
−5.9%Mar 20, 2026
Largest one-day rise
+5.9%Apr 23, 2026
Deepest fall of the year
−14.5%From the close of Jul 28, 2026 to Oct 7, 2026.
Days of 5% or more
3Out of 252 sessions, in either direction.
Beta 0.1(1 year vs SPY)
End-of-day prices. These figures describe the past year and say nothing about what comes next. Beta: how much the stock moved, on average, for each 1% move of the S&P 500 fund over 251 trading days (1 = in step with it).
Owners above 5%
No Schedule 13D or 13G filing on AHR over the last three years: no investor has reported crossing 5% of its stock in that time.
Source: SEC Schedules 13D and 13G, which anyone owning more than 5% of a class of stock must file. A 13D filer may seek to influence the company; a 13G filer is passive. Filings before December 2024 are free text and read from their cover page: a percent or share count that is not stated plainly is left blank. Each line links to the filing.
Red flags in its filings
Sep 2
Top officer leaving
“Peay of his decision to retire as Chief Financial Officer, effective September 30, 2026.”
“Hanson’s termination of service as Interim CEO prior to December 31, 2026 in the same manner described for the time-vesting restricted stock units above.”
From the company's 8-K, 10-K and 10-Q filings over the last two years. A flag is a reason to read the filing, not a verdict: many departures are planned retirements and many listing notices are resolved. Insider sales are shown for timing only; they are separate filings.
Insider buying and selling since 2017
Insiders of American Healthcare REIT reported 192 open-market purchases and 15 sales since 2017; purchases in 4 different years, most recently 2024.
Year
Bought
Sold
2026
—
$2.04M8×8 trades
2025
—
$4.02M6×6 trades
2024
$2.35M3×3 trades
$161×1 trade
2019
$32K5×5 trades
—
2018
$1.57M120×120 trades
—
2017
$575K64×64 trades
—
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
OQRO Intelligence
Written by OQRO's software from the last 12 months on record · Nov 19, 2026
Insiders. In the 12 months to Nov 19, 2026, insiders of American Healthcare REIT filed 0 open-market purchases (about $0, in 0 filings, by 0 people) and 10 open-market sales (about $4.69M, in 9 filings, by 4 people). One Form 4 can list many transactions. In the 12 months before that, they filed 0 open-market purchases (about $0, in 0 filings) and 4 open-market sales (about $1.37M, in 4 filings). (American Healthcare REIT on OQRO)
Funds and stakes. Fund 13F filings recorded in the 12 months show 15 new or larger positions and 4 smaller or closed positions. A 13F is a snapshot of holdings at the end of a quarter.
Contracts, lobbying and filings. FINRA short interest for AHR on the settlement date of Oct 30, 2026 was 33,679,925 shares (+1.51% on the previous report), about 10.26 days of average volume. In 13F filings for the quarter ended Sep 30, 2026, the largest positions that grew: none on record; the largest that shrank: Soros Fund Management (sold out). A 13F is a quarter-end snapshot with no trade date.
Company reports, price and press. American Healthcare REIT filed a Form 8-K on Sep 2, 2026 (Items 5.02, 7.01) that OQRO classes as: changed a top executive or board member, and shared information with investors. The company's own opening sentence of that report reads: "On September 2, 2026, we announced the appointment of Aric Chang as our Chief Financial Officer, effective October 1, 2026, following the September 2, 2026 notification by Brian S. Peay of his decision to retire as Chief Financia..."
Who holds it. 570 funds reported a stake in American Healthcare REIT in their 13F for Q2 2026. The largest by value: BlackRock, Inc. (11.5% of the value reported), VANGUARD PORTFOLIO MANAGEMENT LLC (7.5% of the value reported), VANGUARD CAPITAL MANAGEMENT LLC (4.1% of the value reported).
Things to keep in mind. These are counts of the filings OQRO holds, in the days they were filed; a busy or quiet month does not say why. A Form 4 reports a transaction; it does not say why it was made, and some follow trading windows or pre-arranged plans. Congress reports give only amount ranges and arrive after the trade. Total compensation in a proxy statement counts stock and option awards at their grant-date value, not what was sold.
Facts used for this text
Every number, name, date and link in the text above comes from this list; software checks that before the text is stored. This text was assembled directly from the facts, without a language model.
Insiders
In the 12 months to Nov 19, 2026, insiders of American Healthcare REIT filed 0 open-market purchases (about $0, in 0 filings, by 0 people) and 10 open-market sales (about $4.69M, in 9 filings, by 4 people). One Form 4 can list many transactions.
In the 12 months before that, they filed 0 open-market purchases (about $0, in 0 filings) and 4 open-market sales (about $1.37M, in 4 filings).
The largest sale: Jeffrey T Hanson, Director, about $1.72M, filed Dec 29, 2025.
Funds and stakes
Fund 13F filings recorded in the 12 months show 15 new or larger positions and 4 smaller or closed positions. A 13F is a snapshot of holdings at the end of a quarter.
Contracts, lobbying and filings
FINRA short interest for AHR on the settlement date of Oct 30, 2026 was 33,679,925 shares (+1.51% on the previous report), about 10.26 days of average volume.
In 13F filings for the quarter ended Sep 30, 2026, the largest positions that grew: none on record; the largest that shrank: Soros Fund Management (sold out). A 13F is a quarter-end snapshot with no trade date.
For fiscal 2025, the company's proxy statement reported total compensation of $6.69M for its principal executive officer, and an average of $2.4M for the other named executive officers.
Company reports, price and press
American Healthcare REIT filed a Form 8-K on Sep 2, 2026 (Items 5.02, 7.01) that OQRO classes as: changed a top executive or board member, and shared information with investors.
The company's own opening sentence of that report reads: "On September 2, 2026, we announced the appointment of Aric Chang as our Chief Financial Officer, effective October 1, 2026, following the September 2, 2026 notification by Brian S. Peay of his decision to retire as Chief Financia..."
Latest results: quarter ending Sep 30, 2026
Revenue
$742M
+29.5% vs the same quarter a year earlier
Free cash flow, last 12 months
—
Cash from operations minus capital spending
Net debt
—
Debt —, cash $223M, at Sep 30, 2026
Net income, last 12 months
$96.3M
Operating profit covers interest 7.19x
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Nov 5, 2026.
American Healthcare REIT filed a Form 8-K on Jul 22, 2026 (Items 5.02, 7.01) that OQRO classes as: changed a top executive or board member, and shared information with investors.
The company's own opening sentence of that report reads: "On July 20, 2026, Danny Prosky notified American Healthcare REIT, Inc. (the 'Company') of his decision to retire as Chief Executive Officer and President of the Company, effective as of July 21, 2026."
American Healthcare REIT filed a Form 8-K on Mar 24, 2026 (Item 5.02) that OQRO classes as: changed a top executive or board member.
The company's own opening sentence of that report reads: "On March 23, 2026, we and Mr. Hanson entered into an employment letter agreement, or the Employment Letter, with retroactive effect as of February 4, 2026, outlining the terms of Mr. Hanson’s service as our Interim Chief Executiv..."
Press coverage listed by Finnhub: "Zacks Investment Ideas feature highlights: American Healthcare REIT, RenaissanceRe and Cheniere Energy" (Yahoo, Nov 13, 2026).
Press coverage listed by Finnhub: "American Healthcare REIT: 3 Key Takeaways for Long-Term Investors" (Yahoo, Nov 7, 2026).
Press coverage listed by Finnhub: "American Healthcare REIT Q3 Earnings Call Highlights" (Yahoo, Nov 6, 2026).
AHR closed at $58.55 on Nov 18, 2026, the last session on or before the end of the period.
From Oct 19, 2026 to Nov 18, 2026, the close moved from $52.45 to $58.55, a change of +11.6%.
Who holds it
570 funds reported a stake in American Healthcare REIT in their 13F for Q2 2026. The largest by value: BlackRock, Inc. (11.5% of the value reported), VANGUARD PORTFOLIO MANAGEMENT LLC (7.5% of the value reported), VANGUARD CAPITAL MANAGEMENT LLC (4.1% of the value reported).
Things to keep in mind
These are counts of the filings OQRO holds, in the days they were filed; a busy or quiet month does not say why.
A Form 4 reports a transaction; it does not say why it was made, and some follow trading windows or pre-arranged plans. Congress reports give only amount ranges and arrive after the trade.
Total compensation in a proxy statement counts stock and option awards at their grant-date value, not what was sold.
An 8-K item says what the company reported, not what it means for the share price.
Headlines are listed as published by the outlets; OQRO has not checked them and does not summarise articles.
Share price moves are listed as context only; the filing does not explain them and other news can move a price.
This describes public filings. It is not investment advice.
Latest annual report filed Feb 27, 2026, compared with the one filed Feb 28, 2025. Read the filing
New risk factors in the latest annual report (3 headings)
The use of, or inability to use, artificial intelligence by us, our operators, our tenants and our vendors presents risks and challenges that may adversely impact our business and operating results or the business and operating results of our operators and tenants or may adversely impact the demand for properties.
Mortgage, mezzanine and bridge loans that we may invest in, or have invested in the past, may involve greater risks of loss and negatively impact the value of our investment.
Changes in federal, state or local laws or regulations may limit our opportunities to participate in the ownership of, or investment in, healthcare real estate.
No longer listed (14 headings from the year before)
Our prior performance may not be an accurate predictor of our ability to achieve our business objectives or of our future results.
We may be unable to secure funds for future tenant or other capital improvements, which could limit our ability to attract, replace or retain tenants, pay our expenses and make distributions to our stockholders.
If we contract with a development company for newly developed property, our earnest money deposit made to the development company may not be fully refunded.
We may not retain any profits resulting from the sale of our properties or receive such profits in a timely manner, because we may provide financing to the purchaser of such property.
Representations and warranties made by us in connection with sales of our properties may subject us to liability that could materially and adversely affect us.
Unfavorable real estate market conditions and delays in liquidating defaulted mortgage loan investments may negatively impact mortgage loans in which we have invested and may invest, which could result in losses to us.
The mezzanine loans in which we have invested in the past, and may continue to invest, involve greater risks of loss than senior loans secured by income-producing real estate.
We expect a portion of our real estate-related investments to be illiquid, and we may not be able to adjust our portfolio in a timely manner in response to changes in economic and other conditions.
And 6 more headings in the filing.
Legal proceedings (Item 3)
For a discussion of our legal proceedings, see Note 10, Commitments and Contingencies — Litigation, to the Consolidated Financial Statements that are a part of this Annual Report on Form 10-K.
The company describes its cases in the notes to its financial statements, in the same filing.
Source: SEC EDGAR, Form 10-K filed Feb 27, 2026. Headings are the titles the company gives each risk; OQRO compares them with the year before by their words, so a heading that was reworded a lot shows up as both new and no longer listed. Companies list the risks they face, not forecasts.
When insiders usually buy
Last results
Nov 5, 2026
Within the 30 days after it, until Dec 5, 2026
Next results, expected
Feb 22, 2027
Purchases after results
Not enough history
From American Healthcare REIT's own results filings (8-K Item 2.02) and its insiders' Forms 4 and 5. Many companies only let insiders trade in a period after results; OQRO does not know American Healthcare REIT's policy and only shows the pattern in the filings. A purchase made long after results, at a company whose insiders usually buy right after them, is marked “Bought outside the usual window”.
Where the revenue comes from
Latest quarter
The three months Jul 1, 2026 to Sep 30, 2026, compared with the same quarter a year earlier, from the quarterly report filed Nov 6, 2026. Quarterly reports are not audited. Read the filing
By business segment
ISHC$534M72%
+17% on the same quarter a year earlier ($455M). Operating income $90M, a 17% margin
SHOP$167M22%
+118% on the same quarter a year earlier ($76.6M). Operating income $46.2M, a 28% margin
OM$30.7M4.1%
−1.7% on the same quarter a year earlier ($31.2M). Operating income $18.6M, a 61% margin
Triple-net leased properties$10.4M1.4%
+7.1% on the same quarter a year earlier ($9.7M). Operating income $9.97M, a 96% margin
Total revenue$742M+30%
By region
United States$740M100%
+29% on the same quarter a year earlier ($571M)
International$2.53M0.3%
+52% on the same quarter a year earlier ($1.67M)
Total revenue$742M+30%
The full fiscal year ended Dec 31, 2025
Fiscal year Jan 1, 2025 to Dec 31, 2025, from the annual report filed Feb 27, 2026. Read the filing
By business segment
ISHC$1.76B78%
+8.9% on the year before ($1.62B). Operating income $237M, a 13% margin
SHOP$331M15%
+25% on the year before ($264M). Operating income $64M, a 19% margin
OM$126M5.6%
−6.4% on the year before ($135M). Operating income $77.4M, a 61% margin
Triple-net leased properties$39.5M1.7%
The year in the managers' words
Every annual report has a section where the company's managers explain the year's results (Item 7, Management's discussion and analysis). In this report it runs to about 9,000 words.
From “Overview and Background”, in the company's words
Act of 2007, which is commonly referred to as a “RIDEA” structure. We have also originated and acquired secured loans and may acquire other real estate-related investments in the future on an infrequent and opportunistic basis. We generally seek investments that produce current income; however, we have selectively developed, and may continue to selectively develop, healthcare real estate properties. We have elected to be taxed as a REIT for U.S. federal income tax purposes. We believe that we have been organized and operated, and we intend to continue to operate, in conformity with the requirements for qualification and taxation as a REIT under the Internal Revenue Code of 1986, or the Code.
What the section covers (40 headings)
Overview and Background
Operating Partnership
Public Offering and Listing
Real Estate Investments Portfolio
Key Developments
Critical Accounting Estimates
Real Estate Investments Purchase Price Allocation
Impairment of Long-Lived Assets
Goodwill
Revenue Recognition
Recently Issued Accounting Pronouncements
Acquisitions and Dispositions in 2025, 2024 and 2023
Source: SEC EDGAR, Form 10-K filed Feb 27, 2026 and Form 10-Q filed Nov 6, 2026. Revenue lines are the figures the company tags in its filing; OQRO shows a split only when its lines add up to the reported total revenue. The quote is the opening of the managers' discussion, cut at a sentence; the word count is estimated from its length. Not investment advice.
−24% on the year before ($52.1M). Operating income $36.8M, a 93% margin
Total revenue$2.26B+9.1%
By region
United States$2.25B100%
+9.2% on the year before ($2.06B)
International$6.51M0.3%
−1.7% on the year before ($6.63M)
Total revenue$2.26B+9.1%
Factors Which May Influence Results of Operations
Inflation
And 26 more headings in the filing.
Fails to deliver: 21K shares (about $1.14M) were not delivered on time for settlement on Oct 30, 2026. SEC fails-to-deliver data.
Fails to deliver have many causes, including processing delays, and are often resolved within days.
Off-exchange trading: 41.2% of the shares traded over the latest 4 published weeks changed hands away from the exchanges (23.9% on ATS, 17.3% with other brokers), close to its 26-week average of 41.5%. Weeks of Oct 5 to Oct 30, 2026.
Week of May 4ATSOther off-exchangeFull height = all shares tradedWeek of Oct 26
Largest ATS: UBS ATS (13.8%), INTELLIGENT CROSS LLC (12.7%), SIGMA X2 (8.6%), as a share of this stock's ATS volume over the same 4 weeks.
An ATS, often called a dark pool, is a private trading venue run by a broker where orders are not shown publicly before they trade. Other off-exchange trades are mostly retail orders filled by wholesale brokers. A high share is common and says nothing by itself about where the price goes. FINRA OTC Transparency data, published 2 weeks after each week for the largest stocks and 4 weeks for others; total volume from our daily price data.